Generate Biomedicines, Inc. (GENB) research

Generate Biomedicines, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$17.46
As of

Generate Biomedicines, Inc. (GENB): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-26.

As of . Source: SEC EDGAR filings for GENB. Method and limitations.

SHARE THIS CARD

Share the GENB intelligence card

A branded snapshot of GENB: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion GENB intelligence card preview
Post to X
LIVE TERMINAL

See GENB live in the terminal

Track GENB's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live GENB terminal, free

Active signals for GENB

FREE, NO ACCOUNT

Every signal on GENB, as it fires

You are seeing 5 of 16 signals recorded on GENB since 2026-05-27.

The five above all landed on 2026-09-06. The other 11 were recorded on 4 other days. 14 of the 16 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in GENB (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 370920100 · 2026Q2$669K0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 370920100 · 2026Q2$370K0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 370920100 · 2026Q2$310K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, GENB

Related tickers

See more GENB signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GENBand get the insider, 13F, options, and confluence read in one view.

Open the live GENB terminal, free